Venn Biosciences Corp — Form D
Venn Biosciences Corp of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-28. The offering totals $31.7M, of which $31.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-28
- Form: D
- Accession: 0001756172-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $31.7M
- Amount sold: $31.7M
- Investors: 14
- Date of first sale: 2020-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371966
Issuer
- Name: Venn Biosciences Corp
- CIK: 0001756172
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2 TOWER PLACE, 5TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 1-888-706-1670
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Adam D'Augelli | Director | Boston, MA |
| Jenny Rooke | Director | Waltham, MA |
| David Michael | Director | Billerica, MA |
| Aldo Carrascoso | Director | SOUTH SAN FRANCISCO, CA |
| Aldo Carrascoso | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Klaus Lindpaintner | Director | South San Francisco, CA |
| Lieza Danan-Leon | Director | San Bruno, CA |
Other filings by this issuer (4)
More